Beloteca Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BELOTECA, and what generic and branded alternatives to BELOTECA drugs are available?
BELOTECA has five approved drugs.
Drugs and US Patents for Beloteca
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beloteca | THIOTEPA | thiotepa | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | 217559-001 | Aug 20, 2024 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Beloteca | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 210714-001 | Jan 16, 2019 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Beloteca | DIAZEPAM | diazepam | INJECTABLE;INJECTION | 210363-001 | Mar 18, 2019 | AP | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
Beloteca | THIOTEPA | thiotepa | INJECTABLE;INJECTION | 211831-001 | Dec 8, 2021 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.